Insights

Innovative Diagnostic Platform Credo Diagnostics Biomedical has developed the VitaPCR platform, capable of delivering rapid molecular test results within 20 minutes. This cutting-edge technology can be appealing to healthcare providers and laboratories seeking fast, reliable diagnostics for infectious diseases like COVID-19, influenza, and RSV.

Expanding Market Reach With a strong focus on Point-of-Care molecular diagnostics, Credo is positioned to serve both human and veterinary markets, providing opportunities to engage hospitals, clinics, veterinary practices, and diagnostic labs looking for cost-effective testing solutions.

Growth in Revenue Scale Generating between one to ten million USD, Credo presents opportunities to target mid-sized healthcare providers and regional distributors who are expanding their diagnostic offerings with rapid testing technology.

Technology Adoption Needs The company's reliance on technology stacks like WordPress, Shopify, and Microsoft 365 indicates a modern, digitally connected operation. Offering complementary digital solutions or integration services could help enhance their testing and distribution workflows.

Funding and Industry Position While specific funding data is unavailable, Credo's recent product launch and innovative platform suggest potential for attracting investors or partners interested in cutting-edge molecular diagnostics, opening avenues for collaboration or funding opportunities to accelerate growth.

Similar companies to Credo Diagnostics Biomedical

Credo Diagnostics Biomedical Tech Stack

Credo Diagnostics Biomedical uses 8 technology products and services including 33Across, WordPress, Shopify, and more. Explore Credo Diagnostics Biomedical's tech stack below.

33Across
Advertising
WordPress
Content Management System
Shopify
E-commerce
Microsoft 365
Email
Font Awesome
Font Scripts
imagesLoaded
Javascript Libraries
reCAPTCHA
Security
Weglot
Translation

Media & News

Credo Diagnostics Biomedical Pte. Ltd launched VitaPCR TM on Jan 1st '19.
Founded in 2011, Credo Diagnostics launched the VitaPCR TM in 2019, a revolutionary molecular biology platform capable of detecting infectious pathogens (including the SARS-CoV-2 responsible for Covid-19, influenza and RSV viruses) by Polymerase Chain Reaction (PCR) methodology in only 20 minutes.
Jan 13, 2023 | www.marketscreener.com

Credo Diagnostics Biomedical's Email Address Formats

Credo Diagnostics Biomedical uses at least 1 format(s):

Credo Diagnostics Biomedical Email Formats	Example	Percentage
First.Last@credodxbiomed.com	John.Doe@credodxbiomed.com	42%
FMiddleLast@credodxbiomed.com	JMichaelDoe@credodxbiomed.com	8%
First.Last@credodxbiomed.com	John.Doe@credodxbiomed.com	42%
FMiddleLast@credodxbiomed.com	JMichaelDoe@credodxbiomed.com	8%

Frequently Asked Questions

Where is Credo Diagnostics Biomedical's headquarters located?

Credo Diagnostics Biomedical's main headquarters is located at 491b River Valley Road, #06-01. The company has employees across 2 continents, including AsiaEurope.

What is Credo Diagnostics Biomedical's official website and social media links?

Credo Diagnostics Biomedical's official website is credodxbiomed.com and has social profiles on LinkedIn.

What is Credo Diagnostics Biomedical's NAICS code?

Credo Diagnostics Biomedical's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Credo Diagnostics Biomedical have currently?

As of December 2025, Credo Diagnostics Biomedical has approximately 201 employees across 2 continents, including AsiaEurope. Key team members include Chairman: W. J. W.Head, Chairman’s Office / Vice President: T. T.Vp: S. K.. Explore Credo Diagnostics Biomedical's employee directory with LeadIQ.

What industry does Credo Diagnostics Biomedical belong to?

Credo Diagnostics Biomedical operates in the Medical Equipment Manufacturing industry.

What technology does Credo Diagnostics Biomedical use?

Credo Diagnostics Biomedical's tech stack includes 33AcrossWordPressShopifyMicrosoft 365Font AwesomeimagesLoadedreCAPTCHAWeglot.

What is Credo Diagnostics Biomedical's email format?

Credo Diagnostics Biomedical's email format typically follows the pattern of First.Last@credodxbiomed.com. Find more Credo Diagnostics Biomedical email formats with LeadIQ.

When was Credo Diagnostics Biomedical founded?

Credo Diagnostics Biomedical was founded in 2011.

Credo Diagnostics Biomedical

Q: What technology does Credo Diagnostics Biomedical use?

Credo Diagnostics Biomedical's tech stack includes Yoast SEO, Shopify, jQuery, imagesLoaded, Bootstrap.

Medical Equipment ManufacturingCentral Region, Singapore201-500 Employees

Credo Diagnostics Biomedical develops, manufactures, and commercializes innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of human infectious diseases and animal health.

At Credo Diagnostics Biomedical, we are conscious of the necessity to simplify processes and accelerate molecular testing at lower costs. We believe that effective rapid POC Molecular Diagnostics will redefine healthcare for both human and veterinary clinical management. 

By providing the right information, at the right time, and to the right people, we can improve the lives of billions of people and animals around the world. 

For any inquiries, please contact us at: service@credodxbiomed.com